生物科技與製藥產業學
New drug development and biopharmaceutical industry
| 節 | 週四 |
|---|---|
1 08:00–08:50 | 生物科技與製藥產業學 YR103（陽明） 2 節連堂 |
2 09:00–09:50 |
* 根據陽明交大上課時間表所列
教師未提供此項資料
教師未提供此項資料
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | Introduction 2020/03/05 |
| 第 2 週 | From bench to bedside (I) From bench to bedside (I) 2020/03/12 |
| 第 3 週 | From bench to bedside (II)From bench to bedside (II) 2020/03/19 |
| 第 4 週 | The current status of new drug development 2020/03/26 |
| 第 5 週 | Early discovery processes of drug development 2020/04/02 |
| 第 6 週 | The investigational new drug (IND) application 2020/04/09 |
| 第 7 週 | 清明節停課Design and statistical issues for phase I trial 2020/04/16 |
| 第 8 週 | Design and statistical issues for phase I trialPatent application and maintenance 2020/04/23 |
| 第 9 週 | Patent application and maintenanceDesign and statistical issues for phase II trial 2020/04/30 |
| 第 10 週 | Design and statistical issues for phase II trialPress release and investor relationship 2020/05/07 |
| 第 11 週 | Press release and investor relationshipDesign and statistical issues for phase III trial 2020/05/14 |
| 第 12 週 | Design and statistical issues for phase III trialPortfolio evaluation in biotech 2020/05/21 |
| 第 13 週 | Portfolio evaluation in biotechCase studies of new startup biotech companies 2020/05/28 |
| 第 14 週 | Case studies of new startup biotech companiesRegulatory aspects of drug development 2020/06/04 |
| 第 15 週 | Regulatory aspects of drug developmentMerger and acquisition in biotech/pharm industry 2020/06/11 |
| 第 16 週 | Merger and acquisition in biotech/pharm industryCase study and report (I) 2020/06/18 |
| 第 17 週 | Case study and report (I)Case study and report (II) 2020/06/25 |
| 第 18 週 | Case study and report (II)Case study and report (III) 2020/07/02 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料